Top Markets
#1 GALA GALA +34.47%
#2 Magma Finance Magma Finance +32.81%
#3 Wrapped STX (Velar) Wrapped STX (Velar) +32.48%
#4 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +30.91%
#5 Bitcoin Cash Bitcoin Cash +30.80%
#6 Talus Network Talus Network +29.71%
#7 TROLL TROLL +28.68%
#8 Useless Coin Useless Coin +28.50%
#9 Bless Bless +28.17%
#10 Ethereum Name Service Ethereum Name Service +28.00%
Coin of the day
GALA GALA
설정
언어
한국어
통화
USD
테마
Achilles Therapeutics plc Achilles Therapeutics plc

Achilles Therapeutics plc

ACHL
주식 순위 #24579
Achilles Therapeutics Plc is a clinical-stage biopharmaceutical company focused... Achilles Therapeutics Plc is a clinical-stage biopharmaceutical company focused on immuno-oncology. The firm specializes in creating innovative precision T-cell therapies designed to combat a range of solid tumors. Its primary therapeutic candidates, both currently undergoing Phase I/IIa clinical trials, are CHIRON, aimed at advanced non-small cell lung cancer, and THETIS, targeting metastatic or recurrent melanoma. Beyond these, Achilles is also advancing its pipeline with treatments for head and neck squamous cell carcinoma, renal cell carcinoma, triple-negative breast cancer, and bladder cancer. Initially incorporated as Achilles TX Limited, the company officially adopted the name Achilles Therapeutics Plc in February 2021. Established in 2016, its corporate headquarters are situated in London, United Kingdom.
주가
$1.48
마지막 동기화: 2025-03-24
시가총액
$59.05M
변동 (1일)
0.00%
변동 (1년)
0.00%
국가
GB
거래 Achilles Therapeutics plc (ACHL)

카테고리

Healthcare
Achilles Therapeutics plc (ACHL)의 수익
2026 기준 수익 TTM: 0
Achilles Therapeutics plc의 최신 재무 보고서에 따르면 회사의 현재 수익은 0입니다. 2026년에 회사는 0의 수익을 올렸으며 이는 2026년의 수익 0과 동일입니다. 이 페이지에 표시된 수익은 이자 및 세금 공제 전 수익으로, 즉 EBIT입니다.
Achilles Therapeutics plc의 수익 기록 (2026 ~ 2026)
연말 수익
연도 수익 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 수익
회사 수익 수익 차이 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH